SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences (GLSI) is trending due to impressive preliminary Phase 3 trial results showing an 80% reduction in breast cancer recurrence, alongside an extended insider lock-up signaling strong management confidence. This news has ignited intense community discussion about its low float, extremely high cost to borrow, and significant short interest, leading to widespread speculation of a substantial short squeeze and a potential multi-billion dollar valuation for its breast cancer therapy.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is currently capturing significant attention, driven by enthusiastic discussions around the impending LitVM airdrop and the launch of its Omnichain system, which introduces new yield-earning capabilities. The community is actively debating strong bullish prospects and favorable technical indicators, reinforcing its long-held narrative as "digital silver" within the broader crypto market.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

Ultragenyx Pharmaceutical is trending after its setrusumab drug for osteogenesis imperfecta failed to meet primary endpoints in late-stage trials, prompting a significant stock decline. The community is actively debating whether this represents an overreaction, pointing to the company's existing approved products and deep pipeline as reasons for a potential rebound.

TryHard Holdings Ltd. is a lifestyle entertainment company that operates in Japan offering a diverse range of services across the entertainment and hospitality sectors. It operates through the following business segments: Consultancy and management, Event curation, Sub-leasing and Restaurants. The Consultancy and management segment provides expert services to clubs, including operations, event management, and strategic support to enhance performance and engagement. The Event curation segment organize and produce own events, also provides a full suite of services, including event planning, construction, entertainment booking, event operation, and ticket sales. The Sub-Leasing segment acts as an intermediary between landlords and clubs. The Restaurants segment operates several restaurants. The company was founded on October 16, 2013 and is headquartered in Osaka, Japan.

TryHard Holdings Ltd.

TryHard Holdings Ltd. ($THH) is a top trending stock following its recent Initial Public Offering (IPO) on NASDAQ, with community discussion centered on its high volatility as a low-float play. While some investors are optimistic about its significant price appreciation potential, others are highly skeptical, raising concerns about its dramatic price swings and labeling it as a potential "pump and dump."

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital is trending amidst significant year-end tax-loss harvesting, with the community expressing widespread frustration over its notable underperformance and perceived management issues, particularly regarding share dilution. Despite the stock trading at a discount to its Bitcoin holdings, proponents highlight its strategic pivot into AI/HPC data centers and substantial short interest as potential catalysts for a rebound.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust (SLV) is experiencing intense trading activity amidst a sharp price pullback, largely attributed to increased margin requirements by a major commodities exchange triggering forced liquidations. Investors are fiercely debating whether this represents a "buy the dip" opportunity, fueled by concerns over looming export restrictions from a key global consumer and persistent supply/demand imbalances, or if it signals an unsustainable top after a parabolic ascent. This market action underscores the deep divide between perceived paper market manipulation and the fundamental outlook for physical silver.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.Retry

Cardano

Cardano ($ADA) is currently a hotbed of intense community FUD, with many investors vehemently labeling it a 'scam' and predicting significant 'rugpulls' and 'dumps,' largely blaming its founder Charles Hoskinson. Despite widespread bearish sentiment suggesting the project is 'dead,' a smaller segment is actively accumulating, anticipating a future market resurgence or positive legislative impact like a 'Clarity Act' run. The pervasive negative sentiment, fueled by perceived price underperformance, is the immediate catalyst driving conversation around $ADA.

ImageneBio, Inc. is a clinical-stage biotechnology company that boldly imagines a world where patients can be free from the burden of grievous immunological/autoimmune and inflammatory (I&I) diseases. It focuses on the development of new medicines with differentiated profiles that can effectively control and change the course of I&I diseases for affected patients, treat their symptoms, and improve quality of life. The company was founded in February 2016, and is headquartered in San Diego, CA.

ImageneBio Inc.

ImageneBio, Inc.

ImageneBio ($IMA) is seeing heightened discussion due to conflicting analyst ratings, with Wedbush's $2 target contrasting sharply with Leerink's Outperform rating and $30 target. The stock has experienced recent volatility, attributed by some to competitor news, leading to a community debate over its significant cash value and the potential for its differentiated Atopic Dermatitis treatment, IMG-007, despite a long timeline to key Phase 2b data. Many investors are weighing the substantial institutional backing against concerns about program timelines and recent share price weakness.

ProShares Trust - ProShares UltraShort Silver -2x Shares

ProShares UltraShort Silver

ProShares UltraShort Silver (ZSL) is trending as silver prices experience a sharp reversal, primarily driven by a major commodities exchange raising margin requirements. The community is actively discussing aggressive shorting strategies and capitalizing on the pullback after silver's recent significant run. Many traders are positioning to bet against the metal following its prior parabolic ascent.

#c8ntinuum is rewriting the narrative — prioritizing cooperation over competition among blockchains. Multichain powered protocol unleashing unrivaled mechanisms designed to achieve ultimate interoperability, scalability, and long term sustainability.  c8ntinuum is the first permissionless Layer 0 protocol that supports multiple layers, enabling trust-minimized and secure multi-chain interoperability through zero-knowledge on-chain light clients.

c8ntinuum

CTM is garnering significant attention as community members identify 'Castellum' as a high-risk, high-reward 'sleeper' asset with substantial untapped potential. Discussions highlight strong conviction that it represents a massive opportunity for a long-term swing play.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BCB Bancorp, Inc. (NJ) (NASDAQ:BCBP) Stock Price Crosses Below Two Hundred Day Moving Average - Time to Sell?

BCB Bancorp, Inc. (NJ) (NASDAQ:BCBP) Share Price Crosses Below 200-Day Moving Average - Here's What Happened...

Are Options Traders Betting on a Big Move in BCB Bancorp Stock?

Investors need to pay close attention to BCBP stock based on the movements in the options market lately. 

BCB Bancorp, Inc. (NJ) (NASDAQ:BCBP) Upgraded by Wall Street Zen to "Hold" Rating

Wall Street Zen raised BCB Bancorp, Inc. (NJ) from a "sell" rating to a "hold" rating in a research note on Friday...

LSV Asset Management Cuts Stock Position in BCB Bancorp, Inc. (NJ) $BCBP

LSV Asset Management decreased its position in shares of BCB Bancorp, Inc. (NJ) (NASDAQ:BCBP - Free Report) by 31.5% in the second quarter, according to its most recent Form 13F filing with the...

BCB Bancorp, Inc. (NJ) $BCBP Shares Sold by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. lowered its stake in shares of BCB Bancorp, Inc. (NJ) (NASDAQ:BCBP - Free Report) by 60.5% during the second quarter, according to its most recent Form...

P/E Ratio Insights for BCB Bancorp

BCB Bancorp, Inc. (NJ) (NASDAQ:BCBP) Downgraded by Wall Street Zen to Sell

Wall Street Zen downgraded shares of BCB Bancorp, Inc. (NJ) from a "hold" rating to a "sell" rating in a report on Saturday...

Here's What Key Metrics Tell Us About BCB Bancorp (BCBP) Q3 Earnings

Although the revenue and EPS for BCB Bancorp (BCBP) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

BCB Bancorp (BCBP) Q3 Earnings and Revenues Beat Estimates

BCB Bancorp (BCBP) delivered earnings and revenue surprises of +4.76% and +3.02%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Is the Options Market Predicting a Spike in BCB Bancorp Stock?

Investors need to pay close attention to BCB Bancorp stock based on the movements in the options market lately.

BCB Bancorp, Inc. is a holding company, which engages in the provision of financial solutions. It offers loans, deposit products, and retail and commercial banking services. The company was founded on May 1, 2003 and is headquartered in Bayonne, NJ.

BCBP
BCB Bancorp Inc (NJ)

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BCBP News

BCBPBCB Bancorp Inc (NJ)